FDA official logo
GSRS logo
PFDA official logo

EFALIZUMAB

  • UNII: XX2MN88N5D
  • Preferred Substance Name: EFALIZUMAB

  • 214745-43-4
  • ANTI-CD11A
  • EFALIZUMAB [EMA EPAR]
  • EFALIZUMAB [HSDB]
  • EFALIZUMAB [INN]
  • EFALIZUMAB [MART.]
  • EFALIZUMAB [MI]
  • EFALIZUMAB [USAN]
  • EFALIZUMAB [VANDF]
  • EFALIZUMAB [WHO-DD]
  • HU1124
  • HU-1124
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CD11A (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HU1124 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HU1124 LIGHT CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CD11A (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HU1124 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HU1124 LIGHT CHAIN, DIMER

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.